Invention Grant
US09279005B2 Fusion proteins and their use in the diagnosis and treatment of leishmaniasis
有权
融合蛋白及其在利什曼病诊断和治疗中的应用
- Patent Title: Fusion proteins and their use in the diagnosis and treatment of leishmaniasis
- Patent Title (中): 融合蛋白及其在利什曼病诊断和治疗中的应用
-
Application No.: US14286647Application Date: 2014-05-23
-
Publication No.: US09279005B2Publication Date: 2016-03-08
- Inventor: Ajay Bhatia , Steven G. Reed
- Applicant: Infectious Disease Research Institute
- Applicant Address: US WA Seattle
- Assignee: Infectious Disease Research Institute
- Current Assignee: Infectious Disease Research Institute
- Current Assignee Address: US WA Seattle
- Agency: Morrison & Foerster LLP
- Main IPC: G01N33/569
- IPC: G01N33/569 ; C12P21/04 ; A61K39/008 ; C07K14/44 ; G01N33/68 ; C07K16/20 ; A61K38/00 ; A61K39/00
Abstract:
The present invention relates generally to a fusion protein made from a synthetic gene construct comprising of elements derived from the Leishmania antigens K26, K39, and K9. The fusion protein is particularly useful in the diagnosis of leishmaniasis, particularly visceral leishmaniasis in animals such as humans and dogs.
Public/Granted literature
- US20150017200A1 FUSION PROTEINS AND THEIR USE IN THE DIAGNOSIS AND TREATMENT OF LEISHMANIASIS Public/Granted day:2015-01-15
Information query
IPC分类:
